Skip to main content
. 2014 Dec 10;6(4):2009–2022. doi: 10.18632/oncotarget.2987

Figure 5. FGFR2 positive tumors showed copositivity of enriched drug resistance related RTKs.

Figure 5

Representative immunohistochemical analysis of one patient with FGFR2 positive GC is shown. Copositivity of HER3, MET and EGFR were accompanied by FGFR2 positivity.